Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07455136 · ClinicalTrials.gov registry record

A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury

A clinical trial of Traumatic Brain Injury, sponsored by Hoffmann-La Roche.

Recruiting
Registry status
2,000
Enrollment target
9
Study locations

NCT07455136 is a study of Traumatic Brain Injury that is actively recruiting participants, run by Hoffmann-La Roche. The registered enrollment target is 2,000 participants, above the 266-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (652% higher). The trial reports 9 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07455136, a study of Traumatic Brain Injury, is actively recruiting participants, sponsored by Hoffmann-La Roche.

RECRUITING
Registry status
2,000 participants
Enrollment target
9
Study locations

Study Summary

The study is intended to cover two purposes: first, to develop a blood-based biomarker test for aiding the diagnosis of traumatic brain injury (TBI) in adult participants and for prognosis of outcome of TBI (CLIN12.1); and second, for monitoring the development of secondary events in adult participants diagnosed with TBI (CLIN12.2).

Conditions Studied

Traumatic Brain Injury

Interventions

  • PROCEDURE Blood sample collection

Study Locations (9)

California

  • University Of California Davis, Neurological Surgery - Sacramento
  • University of California San Francisco - San Francisco

Pennsylvania

  • University of Pennsylvania Medical Center - Philadelphia
  • University of Pittsburgh Medical Center - Pittsburgh

Indiana

  • Goodman Campbell Brain and Spine/Ascension - Carmel

North Carolina

  • Atrium Health - Carolina Medical Center - Charlotte

Ohio

  • University of Cincinnati - Cincinnati

Tennessee

  • Vanderbilt University Medical Center - Nashville

Wisconsin

  • Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2026-02-09
Est. Completion 2028-05-31

Sponsor

Hoffmann-La Roche

909 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07455136

The ClinicalTrials.gov registry entry for NCT07455136 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 266-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (652% higher). The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Blood sample collection is the first listed.

NCT07455136 reports 9 study locations spanning 7 distinct geographic areas - top geographies include California, Pennsylvania, Indiana.

Frequently Asked Questions

What is clinical trial NCT07455136 about?

NCT07455136 is a clinical study titled "A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury". The study is intended to cover two purposes: first, to develop a blood-based biomarker test for aiding the diagnosis of traumatic brain injury (TBI) in adult participants and for prognosis of outcome of TBI (CLIN12.1); and second, for monitoring the development of secondary events in adult participa...

What is the current status of trial NCT07455136?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2026-02-09. Estimated completion is 2028-05-31.

What conditions does trial NCT07455136 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

What interventions are being tested in trial NCT07455136?

The interventions under investigation include: Blood sample collection (PROCEDURE).

Who is sponsoring clinical trial NCT07455136?

This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07455136 being conducted?

This trial has 9 study locations across California, Indiana, North Carolina, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Traumatic Brain Injury

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.